http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-15002003-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2002-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66710bbfa0ae5a6fa7d8963b396c0308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_385443cd012b9c44db3ee4efac1f5f98
publicationDate 2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SK-15002003-A3
titleOfInvention Use of 3- [1- [2- (1-acetyl-2,3-dihydro-1H-indol-3-yl) -ethyl] -1,2,3,6-tetrahydropyridin-4-yl] -6-chloro- 1H-indole
abstract The use of 3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1H-indole, any of its enantiomers and pharmaceutically acceptable salts thereof for the preparation of a pharmaceutical composition for the treatment of attention deficit hyperactivity disorder.
priorityDate 2001-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414443800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9911899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414582694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9910014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421479203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410893834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394901

Total number of triples: 41.